FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/04/2024
Back to search
Official data from USPTO
FUJIREBIO NEURO CENTER OF EXCELLENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
03/04/2024
Trademark type
Combined
Nice classes
42
Filing date
06/06/2022
Registration date
11/07/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/07/2023
Last transaction
11/07/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
JP
Examiner
PARKS, KIMBERLY
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "FUJIREBIO NEURO CENTER OF EXCELLENCE" in black to the right of a black vertical line; a design of two hands outlined in blue sit below an incomplete circle design consisting of two halves; one side being a half of a brain outlined in green, and the other side being half of a globe outlined in blue. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark.
Holders and representatives
Holders
Fujirebio Inc.
Representatives
Gabrielle S. Roth Sughrue Mion, PLLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research services for reagents for medical use in the field of neurology; research services for reagents for medical use; medical research and medical analysis for medical research in the field of neurologyconsulting relating thereto; analysis for medical research and medical research services and consulting about the aforesaid; scientific testinganalysis and research for medical purposes in the field of neurology; scientific testinganalysing and research for medical purposes in the field of neurology; scientific and medical research and development in the field of neurology; scientific and medical research and development in the field of neurology; testinginspection and research of chemicals and pharmaceuticals in the field of neurology; testinginspection and research of chemicals and pharmaceuticals; testinginspection and research of cosmetics and foodstuffs; research and development in the field of diagnostic preparations relating to neurology; research and development in the field of diagnostic preparations; providing information relating to medical research in the field of medicinechemistry and diagnostics relating to neurology; providing information relating to medical research in the field of medicinechemistry and diagnostics; working on and evaluation of chemical analyses in the field of neurology; working on and evaluation of chemical analyses; consultancy in the field of chemistry relating to neurology; consultancy in the field of chemistry; testinginspection and research of chemicals and pharmaceuticals relating to chemistry in the field of neurology; testinginspection and research of diagnostic agents relating to chemistry; testinginspectionresearchevaluation and analysis of chemical ingredients in the field of neurology; testinginspectionresearchevaluation and analysis of chemical ingredients; product research and development services; product development consultancy; providing quality assurance services in the field of neurology; quality assurance consultancy services in the field of neurology; product quality testing; material testing and analysis for product quality; testing the functionality ofresearch onmachinesapparatus and instruments; testing the functionality ofresearch relating tomedical apparatus and instruments in the field of neurologytheir parts; testing the functionality ofresearch relating tomedical apparatus and instruments and their parts; design of medical apparatus and instruments in the field of neurology; design of medical apparatus and instruments; design and development of diagnostic apparatus; design and development of medical diagnostic apparatus in the field of neurology; design and development of medical diagnostic apparatus; rental of laboratory apparatus for chemical substances in the field of neurology; rental of laboratory apparatus for chemical substances; rental of measuring apparatus; rental of measuring and laboratory machines and instruments; rental of laboratory apparatus and instruments; rental of computers; providing computer programs on data networksproviding temporary use of online non-downloadable software for database management in the field of neurology; computer software designcomputer programmingmaintenance of computer software; scientific and medical research and development in the field of neurology by collaborating with third parties; scientific and medical research and development by collaborating with third parties; scientific researchtesting and analysis services by engineers and scientiststheir technological consultancy services in the field of neurology; pharmaceutical product evaluation by engineers and scientistsits technological consultancy services; evaluation of chemical analyses by engineers and scientistsits technological consultancy services
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/09/2024
FIMP
FINAL DISPOSITION PROCESSED
02/09/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/07/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/02/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/22/2023
PUBO
PUBLISHED FOR OPPOSITION
08/22/2023
GPNX
NOTIFICATION PROCESSED BY IB
08/21/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/02/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/02/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/02/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/18/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
07/18/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/18/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
07/18/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/18/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/06/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/06/2023
RFNT
REFUSAL PROCESSED BY IB
06/26/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/06/2023
RFRR
REFUSAL PROCESSED BY MPU
06/06/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/08/2023
CNRT
NON-FINAL ACTION WRITTEN
04/07/2023
DOCK
ASSIGNED TO EXAMINER
03/21/2023
MAFR
APPLICATION FILING RECEIPT MAILED
10/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/07/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/06/2022
Continuous trademark protection
Get notified about every new filing that threatens FUJIREBIO NEURO CENTER OF EXCELLENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.